Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Scientific Reports
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. scientific reports
  3. articles
  4. article
E-selectin-targeted microbubbles combined with ultrasound improves renoprotective effects of methylprednisolone on cisplatin-induced acute kidney injury in rats
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 11 April 2026

E-selectin-targeted microbubbles combined with ultrasound improves renoprotective effects of methylprednisolone on cisplatin-induced acute kidney injury in rats

  • Ruoyan Si1 na1,
  • Liping Mo2 na1,
  • Changan Zhao2 na1,
  • Zeyu Xu2 na1,
  • Wenbao Zhao2,
  • Junfeng Wu3,
  • Rongguo Fu4,5 &
  • …
  • Shuting Ren2,4 

Scientific Reports , Article number:  (2026) Cite this article

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Diseases
  • Drug discovery
  • Medical research
  • Nephrology

Abstract

Our previous study showed that the functionalized E-selectin targeted MBs (TMB-E−selectin) may become a novel drug delivery vector for inflammatory diseases. Therefore, the purpose of this study was to investigate the effect of TMB-E−selectin and methylprednisolone (MP) co-administration combined with ultrasound (US) on cisplatin-induced acute kidney injury (AKI) in rats. After modeling with a single intraperitoneal injection of 10 mg/kg of cisplatin, the rats were intravenously administered with MP or TMB-E−selectin alone, or their mixtures. US was immediately applied for 10 min on bilateral kidneys in rats with TMB-E−selectin treatment. Results showed that 50 mg/kg MP alone and the mixture of 20 mg/kg MP and 500 µL/kg TMB-E−selectin combined with US significantly reduced the levels of BUN and Scr, renal injuries, and the expressions of E-selectin, IL-1α, TNF-α, and NF-κB in renal tissues, but these therapy effects were not significantly observed by 20 mg/kg MP alone. In conclusion, TMB-E−selectin combined with US can enhance the anti-inflammatory and renoprotective effects of the MP in rats with AKI then decrease systemic required dosage and improve the bioavailability of glucocorticoids, which mechanism mainly associates with local drug delivery mediated by US targeted microbubbles cavitation.

Data availability

The data for this study findings are available within the article.

References

  1. Fung, A. T. et al. Local delivery of corticosteroids in clinical ophthalmology: A review. Clin. Exp. Ophthalmol. 48, 366–401. https://doi.org/10.1111/ceo.13702 (2020).

    Google Scholar 

  2. Fournier, L., de La Taille, T. & Chauvierre, C. Microbubbles for human diagnosis and therapy. Biomaterials 294, 122025. https://doi.org/10.1016/j.biomaterials.2023.122025 (2023).

    Google Scholar 

  3. Li, H. et al. Highlights in ultrasound-targeted microbubble destruction-mediated gene/drug delivery strategy for treatment of malignancies. Int. J. Pharm. 613, 121412. https://doi.org/10.1016/j.ijpharm.2021.121412 (2022).

    Google Scholar 

  4. He, Y. et al. Reversible opening of the blood-labyrinth barrier by low-pressure pulsed ultrasound and microbubbles for the treatment of inner ear diseases. J. Control Release. 372, 318–330. https://doi.org/10.1016/j.jconrel.2024.06.043 (2024).

    Google Scholar 

  5. Mehta, R. I. et al. Ultrasound-mediated blood-brain barrier opening uncovers an intracerebral perivenous fluid network in persons with Alzheimer’s disease. Fluids Barriers CNS. 20, 46. https://doi.org/10.1186/s12987-023-00447-y (2023).

    Google Scholar 

  6. Wang, L. et al. Ultrasound-targeted microbubble destruction augmented synergistic therapy of rheumatoid arthritis via targeted liposomes. J. Mater. Chem. B. 8, 5245–5256. https://doi.org/10.1039/d0tb00430h (2020).

    Google Scholar 

  7. Sharma, D. & Czarnota, G. J. Using ultrasound and microbubble to enhance the effects of conventional cancer therapies in clinical settings. Cancer Metastasis Rev. 44, 39. https://doi.org/10.1007/s10555-025-10255-5 (2025).

    Google Scholar 

  8. Yang, S., Zhang, R., Zhang, H. & Lu, Y. Ultrasound-targeted microbubble destruction: a prospective strategy for treating cardiovascular disease. Front. Cardiovasc. Med. 12, 1634059. https://doi.org/10.3389/fcvm.2025.1634059 (2025).

    Google Scholar 

  9. Wang, Y. et al. Advances in ultrasound-mediated brain drug delivery. J. Pharm. Pharmacol. https://doi.org/10.1093/jpp/rgaf090 (2025).

    Google Scholar 

  10. Si, R. et al. A novel lipid microbubble targeting E-selectin for ultrasound molecular imaging of acute kidney injury in rats. Mol. Pharm. 22, 6163–6173. https://doi.org/10.1021/acs.molpharmaceut.5c00883 (2025).

    Google Scholar 

  11. Yang, Y. et al. Renoprotective approaches and strategies in acute kidney injury. Pharmacol. Ther. 163, 58–73. https://doi.org/10.1016/j.pharmthera.2016.03.015 (2016).

    Google Scholar 

  12. Perse, M. & Veceric-Haler, Z. Cisplatin-induced rodent model of kidney injury: Characteristics and challenges. Biomed. Res. Int. 1462802, https://doi.org/10.1155/2018/1462802 (2018).

  13. Liu, D. et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin. Immunol. 9 https://doi.org/10.1186/1710-1492-9-30 (2013).

  14. Yang, H. et al. The effects of ultrasound-targeted microbubble destruction (UTMD) carrying IL-8 monoclonal antibody on the inflammatory responses and stability of atherosclerotic plaques. Biomed. Pharmacother. 118, 109161. https://doi.org/10.1016/j.biopha.2019.109161 (2019).

    Google Scholar 

  15. Bae, Y. J., Yoon, Y. I., Yoon, T. J. & Lee, H. J. Ultrasound-guided delivery of siRNA and a chemotherapeutic drug by using microbubble complexes: In vitro and in vivo evaluations in a prostate cancer model. Korean J. Radiol. 17, 497–508. https://doi.org/10.3348/kjr.2016.17.4.497 (2016).

    Google Scholar 

  16. Hong, D., Yang, J., Guo, J., Zhang, Y. & Chen, Z. Ultrasound-targeted microbubble destruction enhances inhibitory effect of Apatinib on angiogenesis in Triple negative breast carcinoma xenografts. Anal. Cell. Pathol. (Amst). 2021 8837950, (2021).

    Google Scholar 

  17. Jiang, X. et al. A review of low-intensity pulsed ultrasound for therapeutic applications. IEEE Trans. Biomed. Eng. 66, 2704–2718. https://doi.org/10.1109/TBME.2018.2889669 (2019).

    Google Scholar 

  18. Engelmann, J. et al. Pulsed ultrasound and dimethylsulfoxide gel treatment reduces the expression of pro-inflammatory molecules in an animal model of muscle injury. Ultrasound Med. Biol. 38, 1470–1475. https://doi.org/10.1016/j.ultrasmedbio.2012.03.020 (2012).

    Google Scholar 

  19. Nakamura, T. et al. Low-intensity pulsed ultrasound reduces the inflammatory activity of synovitis. Ann. Biomed. Eng. 39, 2964–2971. https://doi.org/10.1007/s10439-011-0408-0 (2011).

    Google Scholar 

  20. Crossman, J. et al. Low intensity pulsed ultrasound increases mandibular height and Col-II and VEGF expression in arthritic mice. Arch. Oral Biol. 104, 112–118. https://doi.org/10.1016/j.archoralbio.2019.05.032 (2019).

    Google Scholar 

  21. Song, W. S. et al. Neuroprotection by abdominal ultrasound in lipopolysaccharide-induced systemic inflammation. Int. J. Mol. Sci. 24 https://doi.org/10.3390/ijms24119329 (2023).

  22. Fu, S. et al. Protective effect of low-intensity pulsed ultrasound on immune checkpoint inhibitor-related myocarditis via fine-tuning CD4(+) T-cell differentiation. Cancer Immunol. Immunother. 73, 15. https://doi.org/10.1007/s00262-023-03590-5 (2024).

    Google Scholar 

  23. Aibara, Y. et al. Daily low-intensity pulsed ultrasound ameliorates renal fibrosis and inflammation in experimental hypertensive and diabetic nephropathy. Hypertension 76, 1906–1914. https://doi.org/10.1161/HYPERTENSIONAHA.120.15237 (2020).

    Google Scholar 

  24. Liang, W. et al. Low-intensity pulsed ultrasound: A physical stimulus with immunomodulatory and anti-inflammatory potential. Ann. Biomed. Eng. 52, 1955–1981. https://doi.org/10.1007/s10439-024-03523-y (2024).

    Google Scholar 

  25. Yang, T., Liang, C., Chen, L., Li, J. & Geng, W. Low-intensity pulsed ultrasound alleviates hypoxia-induced chondrocyte damage in temporomandibular disorders by modulating the hypoxia-inducible factor pathway. Front. Pharmacol. 11, 689. https://doi.org/10.3389/fphar.2020.00689 (2020).

    Google Scholar 

  26. Cao, Q. et al. Low-intensity pulsed ultrasound of different intensities differently affects myocardial ischemia/reperfusion injury by modulating cardiac oxidative stress and inflammatory reaction. Front. Immunol. 14, 1248056. https://doi.org/10.3389/fimmu.2023.1248056 (2023).

    Google Scholar 

  27. Huang, P. et al. Enhanced antitumor efficacy of ultrasonic cavitation with up-sized microbubbles in pancreatic cancer. Oncotarget 6, 20241–20251. https://doi.org/10.18632/oncotarget.4048 (2015).

    Google Scholar 

Download references

Acknowledgements

The authors thank professor Yili Wang and Liang Bai for help with qRT-PCR. This work was funded by the National Natural Science Foundation of China (grant number 82070792).

Author information

Author notes
  1. These authors contributed equally: Ruoyan Si, Liping Mo, Changan Zhao and Zeyu Xu.

Authors and Affiliations

  1. Department of Ophthalmology, Second Affiliated Hospital, Xi’an Jiaotong University Health Science Center, Xi’an, 710004, People’s Republic of China

    Ruoyan Si

  2. Department of Pathology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center, Xi’an, 710061, People’s Republic of China

    Liping Mo, Changan Zhao, Zeyu Xu, Wenbao Zhao & Shuting Ren

  3. Department of Pathology, School of Basic Medicine and Xijing Hospital, Fourth Military Medical University, Xi’an, 710032, People’s Republic of China

    Junfeng Wu

  4. Department of Nephrology, Second Affiliated Hospital, Xi’an Jiaotong University Health Science Center, Xi’an, 710004, People’s Republic of China

    Rongguo Fu & Shuting Ren

  5. Nephrology & Critical Care Medicine of Xi’an International Science and Technology Cooperation Base, Xi’an, 710004, People’s Republic of China

    Rongguo Fu

Authors
  1. Ruoyan Si
    View author publications

    Search author on:PubMed Google Scholar

  2. Liping Mo
    View author publications

    Search author on:PubMed Google Scholar

  3. Changan Zhao
    View author publications

    Search author on:PubMed Google Scholar

  4. Zeyu Xu
    View author publications

    Search author on:PubMed Google Scholar

  5. Wenbao Zhao
    View author publications

    Search author on:PubMed Google Scholar

  6. Junfeng Wu
    View author publications

    Search author on:PubMed Google Scholar

  7. Rongguo Fu
    View author publications

    Search author on:PubMed Google Scholar

  8. Shuting Ren
    View author publications

    Search author on:PubMed Google Scholar

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Ruoyan Si, Liping Mo, Changan Zhao, Zeyu Xu, Wenbao Zhao, Junfeng Wu, Rongguo Fu and Shuting Ren. The first draft of the manuscript was written by Ruoyan Si and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Rongguo Fu or Shuting Ren.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Si, R., Mo, L., Zhao, C. et al. E-selectin-targeted microbubbles combined with ultrasound improves renoprotective effects of methylprednisolone on cisplatin-induced acute kidney injury in rats. Sci Rep (2026). https://doi.org/10.1038/s41598-026-47547-x

Download citation

  • Received: 17 January 2026

  • Accepted: 01 April 2026

  • Published: 11 April 2026

  • DOI: https://doi.org/10.1038/s41598-026-47547-x

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • E-selectin-targeted lipid microbubbles
  • Ultrasound targeted microbubbles cavitation
  • Drug delivery
  • Glucocorticoids
  • Acute kidney injury
Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • About Scientific Reports
  • Contact
  • Journal policies
  • Guide to referees
  • Calls for Papers
  • Editor's Choice
  • Journal highlights
  • Open Access Fees and Funding

Publish with us

  • For authors
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Scientific Reports (Sci Rep)

ISSN 2045-2322 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research